UniProt ID | AGFG1_HUMAN | |
---|---|---|
UniProt AC | P52594 | |
Protein Name | Arf-GAP domain and FG repeat-containing protein 1 | |
Gene Name | AGFG1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 562 | |
Subcellular Localization | Nucleus . Cytoplasmic vesicle . | |
Protein Description | Required for vesicle docking or fusion during acrosome biogenesis (By similarity). May play a role in RNA trafficking or localization. In case of infection by HIV-1, acts as a cofactor for viral Rev and promotes movement of Rev-responsive element-containing RNAs from the nuclear periphery to the cytoplasm. This step is essential for HIV-1 replication.. | |
Protein Sequence | MAASAKRKQEEKHLKMLRDMTGLPHNRKCFDCDQRGPTYVNMTVGSFVCTSCSGSLRGLNPPHRVKSISMTTFTQQEIEFLQKHGNEVCKQIWLGLFDDRSSAIPDFRDPQKVKEFLQEKYEKKRWYVPPEQAKVVASVHASISGSSASSTSSTPEVKPLKSLLGDSAPTLHLNKGTPSQSPVVGRSQGQQQEKKQFDLLSDLGSDIFAAPAPQSTATANFANFAHFNSHAAQNSANADFANFDAFGQSSGSSNFGGFPTASHSPFQPQTTGGSAASVNANFAHFDNFPKSSSADFGTFNTSQSHQTASAVSKVSTNKAGLQTADKYAALANLDNIFSAGQGGDQGSGFGTTGKAPVGSVVSVPSQSSASSDKYAALAELDSVFSSAATSSNAYTSTSNASSNVFGTVPVVASAQTQPASSSVPAPFGATPSTNPFVAAAGPSVASSTNPFQTNARGATAATFGTASMSMPTGFGTPAPYSLPTSFSGSFQQPAFPAQAAFPQQTAFSQQPNGAGFAAFGQTKPVVTPFGQVAAAGVSSNPFMTGAPTGQFPTGSSSTNPFL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
18 | Dimethylation | EKHLKMLRDMTGLPH HHHHHHHHHHHCCCC | 28.31 | - | |
18 | Methylation | EKHLKMLRDMTGLPH HHHHHHHHHHHCCCC | 28.31 | 115372799 | |
21 | Phosphorylation | LKMLRDMTGLPHNRK HHHHHHHHCCCCCCC | 39.60 | 28857561 | |
38 | Phosphorylation | DCDQRGPTYVNMTVG CCCCCCCCEEEEECC | 42.81 | 22210691 | |
39 | Phosphorylation | CDQRGPTYVNMTVGS CCCCCCCEEEEECCE | 7.92 | 22210691 | |
67 | Phosphorylation | NPPHRVKSISMTTFT CCCCCCCEEEEEECH | 19.62 | 28857561 | |
69 | Phosphorylation | PHRVKSISMTTFTQQ CCCCCEEEEEECHHH | 19.71 | 28857561 | |
71 | Phosphorylation | RVKSISMTTFTQQEI CCCEEEEEECHHHHH | 16.39 | 28857561 | |
72 | Phosphorylation | VKSISMTTFTQQEIE CCEEEEEECHHHHHH | 18.95 | 28857561 | |
74 | Phosphorylation | SISMTTFTQQEIEFL EEEEEECHHHHHHHH | 27.53 | 28787133 | |
83 | Ubiquitination | QEIEFLQKHGNEVCK HHHHHHHHHCHHHHH | 56.48 | - | |
114 | Ubiquitination | FRDPQKVKEFLQEKY CCCHHHHHHHHHHHH | 50.19 | - | |
120 | Acetylation | VKEFLQEKYEKKRWY HHHHHHHHHHHHCCC | 45.83 | 30591935 | |
120 | Ubiquitination | VKEFLQEKYEKKRWY HHHHHHHHHHHHCCC | 45.83 | - | |
123 | Acetylation | FLQEKYEKKRWYVPP HHHHHHHHHCCCCCH | 44.54 | 30591941 | |
124 | Acetylation | LQEKYEKKRWYVPPE HHHHHHHHCCCCCHH | 35.90 | 30591947 | |
138 | O-linked_Glycosylation | EQAKVVASVHASISG HHCCEEEEEEEEECC | 11.65 | 30059200 | |
138 | Phosphorylation | EQAKVVASVHASISG HHCCEEEEEEEEECC | 11.65 | 27080861 | |
142 | O-linked_Glycosylation | VVASVHASISGSSAS EEEEEEEEECCCCCC | 11.47 | 30059200 | |
142 | Phosphorylation | VVASVHASISGSSAS EEEEEEEEECCCCCC | 11.47 | 25159151 | |
144 | O-linked_Glycosylation | ASVHASISGSSASST EEEEEEECCCCCCCC | 30.08 | 30059200 | |
144 | Phosphorylation | ASVHASISGSSASST EEEEEEECCCCCCCC | 30.08 | 25159151 | |
146 | Phosphorylation | VHASISGSSASSTSS EEEEECCCCCCCCCC | 18.88 | 18669648 | |
147 | O-linked_Glycosylation | HASISGSSASSTSST EEEECCCCCCCCCCC | 35.38 | 30059200 | |
147 | Phosphorylation | HASISGSSASSTSST EEEECCCCCCCCCCC | 35.38 | 20068231 | |
149 | O-linked_Glycosylation | SISGSSASSTSSTPE EECCCCCCCCCCCCC | 35.78 | 30059200 | |
149 | Phosphorylation | SISGSSASSTSSTPE EECCCCCCCCCCCCC | 35.78 | 20068231 | |
150 | Phosphorylation | ISGSSASSTSSTPEV ECCCCCCCCCCCCCC | 31.83 | 20068231 | |
151 | O-linked_Glycosylation | SGSSASSTSSTPEVK CCCCCCCCCCCCCCC | 24.97 | 30059200 | |
151 | Phosphorylation | SGSSASSTSSTPEVK CCCCCCCCCCCCCCC | 24.97 | 25159151 | |
152 | Phosphorylation | GSSASSTSSTPEVKP CCCCCCCCCCCCCCC | 33.88 | 20068231 | |
153 | Phosphorylation | SSASSTSSTPEVKPL CCCCCCCCCCCCCCH | 48.33 | 20068231 | |
154 | O-linked_Glycosylation | SASSTSSTPEVKPLK CCCCCCCCCCCCCHH | 24.20 | 30059200 | |
154 | Phosphorylation | SASSTSSTPEVKPLK CCCCCCCCCCCCCHH | 24.20 | 18669648 | |
158 | Acetylation | TSSTPEVKPLKSLLG CCCCCCCCCHHHHHC | 42.86 | 26051181 | |
161 | Methylation | TPEVKPLKSLLGDSA CCCCCCHHHHHCCCC | 47.81 | 115976713 | |
162 | O-linked_Glycosylation | PEVKPLKSLLGDSAP CCCCCHHHHHCCCCC | 36.19 | 30059200 | |
162 | Phosphorylation | PEVKPLKSLLGDSAP CCCCCHHHHHCCCCC | 36.19 | 30266825 | |
167 | Phosphorylation | LKSLLGDSAPTLHLN HHHHHCCCCCEEECC | 34.06 | 25159151 | |
170 | O-linked_Glycosylation | LLGDSAPTLHLNKGT HHCCCCCEEECCCCC | 26.90 | OGP | |
170 | Phosphorylation | LLGDSAPTLHLNKGT HHCCCCCEEECCCCC | 26.90 | 23927012 | |
175 | Acetylation | APTLHLNKGTPSQSP CCEEECCCCCCCCCC | 71.21 | 23236377 | |
175 | Ubiquitination | APTLHLNKGTPSQSP CCEEECCCCCCCCCC | 71.21 | - | |
177 | Phosphorylation | TLHLNKGTPSQSPVV EEECCCCCCCCCCCC | 22.75 | 29255136 | |
179 | Phosphorylation | HLNKGTPSQSPVVGR ECCCCCCCCCCCCCC | 43.03 | 22167270 | |
181 | Phosphorylation | NKGTPSQSPVVGRSQ CCCCCCCCCCCCCCC | 24.81 | 19664994 | |
187 | Phosphorylation | QSPVVGRSQGQQQEK CCCCCCCCCCCHHHH | 32.50 | 26074081 | |
194 | Acetylation | SQGQQQEKKQFDLLS CCCCHHHHHHHHHHH | 47.76 | 18584449 | |
278 (in isoform 2) | Ubiquitination | - | 7.22 | 21906983 | |
291 | O-linked_Glycosylation | HFDNFPKSSSADFGT CCCCCCCCCCCCCCC | 29.75 | 30059200 | |
291 | Phosphorylation | HFDNFPKSSSADFGT CCCCCCCCCCCCCCC | 29.75 | 23401153 | |
292 | O-linked_Glycosylation | FDNFPKSSSADFGTF CCCCCCCCCCCCCCC | 35.35 | 30059200 | |
292 | Phosphorylation | FDNFPKSSSADFGTF CCCCCCCCCCCCCCC | 35.35 | 30278072 | |
293 | O-linked_Glycosylation | DNFPKSSSADFGTFN CCCCCCCCCCCCCCC | 38.66 | 30059200 | |
293 | Phosphorylation | DNFPKSSSADFGTFN CCCCCCCCCCCCCCC | 38.66 | 30278072 | |
298 | O-linked_Glycosylation | SSSADFGTFNTSQSH CCCCCCCCCCCCCCC | 17.44 | 30059200 | |
298 | Phosphorylation | SSSADFGTFNTSQSH CCCCCCCCCCCCCCC | 17.44 | 23898821 | |
301 | O-linked_Glycosylation | ADFGTFNTSQSHQTA CCCCCCCCCCCCHHH | 24.77 | 30059200 | |
301 | Phosphorylation | ADFGTFNTSQSHQTA CCCCCCCCCCCCHHH | 24.77 | 23401153 | |
302 | O-linked_Glycosylation | DFGTFNTSQSHQTAS CCCCCCCCCCCHHHH | 30.69 | 30059200 | |
302 | Phosphorylation | DFGTFNTSQSHQTAS CCCCCCCCCCCHHHH | 30.69 | 25159151 | |
304 | O-linked_Glycosylation | GTFNTSQSHQTASAV CCCCCCCCCHHHHHH | 19.82 | 30059200 | |
304 | Phosphorylation | GTFNTSQSHQTASAV CCCCCCCCCHHHHHH | 19.82 | 21712546 | |
307 | Phosphorylation | NTSQSHQTASAVSKV CCCCCCHHHHHHHHH | 19.70 | 29978859 | |
309 | Phosphorylation | SQSHQTASAVSKVST CCCCHHHHHHHHHHC | 32.37 | 26074081 | |
312 | O-linked_Glycosylation | HQTASAVSKVSTNKA CHHHHHHHHHHCCHH | 27.36 | 30059200 | |
312 | Phosphorylation | HQTASAVSKVSTNKA CHHHHHHHHHHCCHH | 27.36 | 26074081 | |
313 | Acetylation | QTASAVSKVSTNKAG HHHHHHHHHHCCHHH | 33.34 | 26051181 | |
313 | Ubiquitination | QTASAVSKVSTNKAG HHHHHHHHHHCCHHH | 33.34 | - | |
315 | Phosphorylation | ASAVSKVSTNKAGLQ HHHHHHHHCCHHHCC | 29.96 | 24719451 | |
316 | Phosphorylation | SAVSKVSTNKAGLQT HHHHHHHCCHHHCCH | 43.66 | 27251275 | |
318 | Ubiquitination | VSKVSTNKAGLQTAD HHHHHCCHHHCCHHH | 43.87 | 2190698 | |
318 (in isoform 1) | Ubiquitination | - | 43.87 | 21906983 | |
318 (in isoform 3) | Ubiquitination | - | 43.87 | 21906983 | |
323 | Phosphorylation | TNKAGLQTADKYAAL CCHHHCCHHHHHHHH | 41.70 | 26356563 | |
326 | Acetylation | AGLQTADKYAALANL HHCCHHHHHHHHHCC | 34.03 | 26051181 | |
326 | Phosphorylation | AGLQTADKYAALANL HHCCHHHHHHHHHCC | 34.03 | 24719451 | |
327 | Phosphorylation | GLQTADKYAALANLD HCCHHHHHHHHHCCC | 9.54 | 25159151 | |
328 | Phosphorylation | LQTADKYAALANLDN CCHHHHHHHHHCCCC | 11.18 | 27251275 | |
351 | O-linked_Glycosylation | DQGSGFGTTGKAPVG CCCCCCCCCCCCCCC | 30.07 | 30059200 | |
351 | Phosphorylation | DQGSGFGTTGKAPVG CCCCCCCCCCCCCCC | 30.07 | 27642862 | |
359 | O-linked_Glycosylation | TGKAPVGSVVSVPSQ CCCCCCCCEEECCCC | 21.41 | 30059200 | |
359 | Phosphorylation | TGKAPVGSVVSVPSQ CCCCCCCCEEECCCC | 21.41 | 30206219 | |
362 | O-linked_Glycosylation | APVGSVVSVPSQSSA CCCCCEEECCCCCCC | 26.59 | 30059200 | |
362 | Phosphorylation | APVGSVVSVPSQSSA CCCCCEEECCCCCCC | 26.59 | 29255136 | |
365 | O-linked_Glycosylation | GSVVSVPSQSSASSD CCEEECCCCCCCCCC | 40.31 | 30059200 | |
365 | Phosphorylation | GSVVSVPSQSSASSD CCEEECCCCCCCCCC | 40.31 | 29255136 | |
367 | O-linked_Glycosylation | VVSVPSQSSASSDKY EEECCCCCCCCCCHH | 32.01 | 30059200 | |
367 | Phosphorylation | VVSVPSQSSASSDKY EEECCCCCCCCCCHH | 32.01 | 30108239 | |
368 | O-linked_Glycosylation | VSVPSQSSASSDKYA EECCCCCCCCCCHHH | 25.24 | 30059200 | |
368 | Phosphorylation | VSVPSQSSASSDKYA EECCCCCCCCCCHHH | 25.24 | 25159151 | |
370 | O-linked_Glycosylation | VPSQSSASSDKYAAL CCCCCCCCCCHHHHH | 40.80 | 30059200 | |
370 | Phosphorylation | VPSQSSASSDKYAAL CCCCCCCCCCHHHHH | 40.80 | 25159151 | |
371 | O-linked_Glycosylation | PSQSSASSDKYAALA CCCCCCCCCHHHHHH | 37.53 | 30059200 | |
371 | Phosphorylation | PSQSSASSDKYAALA CCCCCCCCCHHHHHH | 37.53 | 30206219 | |
385 | O-linked_Glycosylation | AELDSVFSSAATSSN HHHHHHHHHHCCCCC | 19.53 | 30059200 | |
386 | Phosphorylation | ELDSVFSSAATSSNA HHHHHHHHHCCCCCC | 15.51 | 24719451 | |
389 | O-linked_Glycosylation | SVFSSAATSSNAYTS HHHHHHCCCCCCCCC | 32.19 | 30059200 | |
389 | Phosphorylation | SVFSSAATSSNAYTS HHHHHHCCCCCCCCC | 32.19 | 27251275 | |
391 | O-linked_Glycosylation | FSSAATSSNAYTSTS HHHHCCCCCCCCCCC | 22.56 | 30059200 | |
392 | Phosphorylation | SSAATSSNAYTSTSN HHHCCCCCCCCCCCC | 36.41 | 27251275 | |
395 | O-linked_Glycosylation | ATSSNAYTSTSNASS CCCCCCCCCCCCCCC | 24.10 | 30059200 | |
396 | O-linked_Glycosylation | TSSNAYTSTSNASSN CCCCCCCCCCCCCCC | 19.70 | 30059200 | |
398 | O-linked_Glycosylation | SNAYTSTSNASSNVF CCCCCCCCCCCCCCC | 30.11 | 30059200 | |
401 | O-linked_Glycosylation | YTSTSNASSNVFGTV CCCCCCCCCCCCCCC | 27.05 | 30059200 | |
402 | O-linked_Glycosylation | TSTSNASSNVFGTVP CCCCCCCCCCCCCCE | 34.30 | 30059200 | |
407 | O-linked_Glycosylation | ASSNVFGTVPVVASA CCCCCCCCCEEEEEC | 15.35 | 30059200 | |
421 | O-linked_Glycosylation | AQTQPASSSVPAPFG CCCCCCCCCCCCCCC | 37.14 | 30059200 | |
446 | O-linked_Glycosylation | AAGPSVASSTNPFQT CCCCCCCCCCCCCCC | 35.22 | 30059200 | |
448 | O-linked_Glycosylation | GPSVASSTNPFQTNA CCCCCCCCCCCCCCC | 44.40 | 30059200 | |
456 | Methylation | NPFQTNARGATAATF CCCCCCCCCCCEEEC | 37.03 | 115385871 | |
480 | Phosphorylation | GFGTPAPYSLPTSFS CCCCCCCCCCCCCCC | 25.58 | - | |
481 | O-linked_Glycosylation | FGTPAPYSLPTSFSG CCCCCCCCCCCCCCC | 27.15 | 30059200 | |
489 | O-linked_Glycosylation | LPTSFSGSFQQPAFP CCCCCCCCCCCCCCC | 20.77 | 30059200 | |
544 | Phosphorylation | VSSNPFMTGAPTGQF CCCCCCCCCCCCCCC | 30.48 | - | |
556 | Phosphorylation | GQFPTGSSSTNPFL- CCCCCCCCCCCCCC- | 42.39 | - | |
557 | Phosphorylation | QFPTGSSSTNPFL-- CCCCCCCCCCCCC-- | 33.62 | - | |
558 | Phosphorylation | FPTGSSSTNPFL--- CCCCCCCCCCCC--- | 49.19 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AGFG1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AGFG1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AGFG1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
EPS15_HUMAN | EPS15 | physical | 10613896 | |
A4_HUMAN | APP | physical | 21832049 | |
SUCB1_HUMAN | SUCLA2 | physical | 22939629 | |
GPN1_HUMAN | GPN1 | physical | 22863883 | |
HPBP1_HUMAN | HSPBP1 | physical | 22863883 | |
IPO11_HUMAN | IPO11 | physical | 22863883 | |
OGT1_HUMAN | OGT | physical | 22863883 | |
PPME1_HUMAN | PPME1 | physical | 22863883 | |
SHLB1_HUMAN | SH3GLB1 | physical | 22863883 | |
SURF2_HUMAN | SURF2 | physical | 22863883 | |
TPRKB_HUMAN | TPRKB | physical | 22863883 | |
ZPR1_HUMAN | ZPR1 | physical | 22863883 | |
DPOE2_HUMAN | POLE2 | physical | 25416956 | |
NYAP2_HUMAN | NYAP2 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-177 AND SER-181, ANDMASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-177 AND SER-181, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-177 AND SER-181, ANDMASS SPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-177, AND MASSSPECTROMETRY. |